Status:
COMPLETED
Evolving Treatment Modalities for Management of Patients Suffering From Disc Displacement With Reduction
Lead Sponsor:
Nourhan M.Aly
Conditions:
Temporomandibular Joint Disc Displacement, With Reduction
Eligibility:
All Genders
20-40 years
Phase:
NA
Brief Summary
Aim of the current study is to compare the efficacy of Low Level Laser, Botulinum toxin type A, and repositioning appliance in management of reduced temporomandibular joint disc.
Eligibility Criteria
Inclusion
- TMJ with audible and palpable click.
- Patients with anterior disc displacement as detected by MRI.
- Presence of full or nearly full complement of natural teeth.
Exclusion
- Patients who have radiographic evidence of degenerative conditions of TMJ.
- Patients who have anterior disc dislocation without reduction.
- Previous history of TMD treatment.
- History of recent trauma.
- The presence of systemic diseases (i.e. rheumatoid arthritis, osteoarthritis).
- Inability or unwillingness to undergo magnetic resonance imaging (MRI) such as implanted electronic devices.
- Pregnant and lactating females.
- Patients with known allergy to botulinum toxin type A.
- Patients suffering from neurological disorders.
Key Trial Info
Start Date :
January 10 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2022
Estimated Enrollment :
27 Patients enrolled
Trial Details
Trial ID
NCT05194488
Start Date
January 10 2022
End Date
June 1 2022
Last Update
December 4 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Faculty of Dentistry, Alexandria University
Alexandria, Egypt, 21512